Neola Medical released the Q4 report for 2022 earlier this week. 2022 was an intense year with both a change of name, positive clinical results, ISO certification and a successful capital raise. The company is now working to prepare the Neola lung monitoring system for launch in the US. BioStock contacted CEO Hanna Sjöström for a comment on the year-end report.
Read the entire article here: Neola Medical continues towards market approval
Read the report and the press release (in Swedish) here: Press communication Q4 report 2022